- Home
- NRIX vs PTON Comparison
NRIX vs PTON Comparison
Compare NRIX & PTON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRIX | PTON |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NRIX | PTON |
|---|---|---|
| Price | $24.94 | $6.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $30.50 | $7.89 |
| AVG Volume (30 Days) | 1.1M | ★ 7.2M |
| Earning Date | 04-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.13 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.05 | $0.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $8.20 | $3.65 |
| 52 Week High | $25.09 | $9.20 |
Technical Indicators
Market Signals| Indicator | NRIX | PTON |
|---|---|---|
| Relative Strength Index (RSI) | 66.01 | 58.08 |
| Support Level | $14.63 | $6.40 |
| Resistance Level | $24.98 | $6.65 |
| Average True Range (ATR) | 1.09 | 0.23 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 79.66 | 67.79 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About PTON Peloton Interactive Inc.
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product derives revenue from the portfolio of Connected Fitness Products and related accessories, as well as Precor-branded fitness products, delivery and installation services, Peloton Bike portfolio rental products, extended warranty agreements, branded apparel, and commercial service contracts. Subscription revenue is derived from monthly Subscription fees. The company generates maximum revenue from the Subscription segment. Geographically, the company derives a majority of its revenue from North America and the rest from International markets.